198 related articles for article (PubMed ID: 31247244)
1. Depressive symptoms in schizophrenia patients: A possible relationship between SIRT1 and BDNF.
Fang X; Chen Y; Wang Y; Ren J; Zhang C
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109673. PubMed ID: 31247244
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia.
Wysokiński A
Nord J Psychiatry; 2016; 70(4):267-71. PubMed ID: 26548545
[TBL] [Abstract][Full Text] [Related]
4. Association of biomarkers and depressive symptoms in schizophrenia.
Noto CS; Gadelha A; Belangero SI; Smith MA; de Aguiar BW; Panizzuti B; Mari Jde J; Gama CS; Bressan RA; Brietzke E
Neurosci Lett; 2011 Nov; 505(3):282-5. PubMed ID: 22044873
[TBL] [Abstract][Full Text] [Related]
5. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
6. Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
Eker SS; Yavasci EO; Cangur S; Kirli S; Sarandol E
Acta Neuropsychiatr; 2014 Oct; 26(5):291-7. PubMed ID: 25241757
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
8. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
9. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
[TBL] [Abstract][Full Text] [Related]
10. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
11. The relationship between physical activity, clinical and cognitive characteristics and BDNF mRNA levels in patients with severe mental disorders.
Aas M; Djurovic S; Ueland T; Mørch RH; Fjæra Laskemoen J; Reponen EJ; Cattaneo A; Eiel Steen N; Agartz I; Melle I; Andreassen OA
World J Biol Psychiatry; 2019 Sep; 20(7):567-576. PubMed ID: 30560709
[No Abstract] [Full Text] [Related]
12. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
[TBL] [Abstract][Full Text] [Related]
13. Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.
Liu R; Fang X; Yu L; Wang D; Wu Z; Guo C; Teng X; Ren J; Zhang C
Front Psychiatry; 2021; 12():792019. PubMed ID: 35095605
[No Abstract] [Full Text] [Related]
14. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
15. Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up.
Han D; Sun D; Xiu M; Su X; Wang J; Li J; Wang D
Psychoneuroendocrinology; 2021 Nov; 133():105392. PubMed ID: 34428640
[TBL] [Abstract][Full Text] [Related]
16. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
17. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
[TBL] [Abstract][Full Text] [Related]
19. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
20. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
